Hologic 修订了 2025 年第一季度和财年的收益指引，预计每股收益分别为 1.00 美元至 1.03 美元和 4.25 美元至 4.35 美元。 Hologic revises Q1 and FY 2025 earnings guidance, expecting EPS of $1.00-$1.03 and $4.25-$4.35.
医疗技术公司Hologic修订了其第一季度和2025财年利预测,预计每股收益分别为1.00-1.03美元和4.25-4.35美元. Hologic, a medical technology company, has revised its Q1 and FY 2025 earnings guidance, expecting EPS of $1.00-$1.03 and $4.25-$4.35, respectively. 2025财政年度的最新收入预测为4.15至4.2亿美元。 The updated revenue forecast for FY 2025 is $4.15-$4.20 billion. 分析师保持“机动购买”评级,平均价格目标是87.50美元。 Analysts maintain a "Moderate Buy" rating, with an average price target of $87.50. 霍洛奇公司专业从事诊断,医学成像和女性健康手术产品, 市值为194.5亿美元. Hologic specializes in diagnostics, medical imaging, and surgical products for women's health, and has a market cap of $19.45 billion.